NantKwest, Inc. (NK): Price and Financial Metrics
NK Price/Volume Stats
Current price | $32.49 | 52-week high | $45.42 |
Prev. close | $28.28 | 52-week low | $2.52 |
Day low | $29.74 | Volume | 1,109,000 |
Day high | $33.15 | Avg. volume | 1,568,129 |
50-day MA | $22.98 | Dividend yield | N/A |
200-day MA | $12.74 | Market Cap | 3.55B |
NK Stock Price Chart Interactive Chart >
NantKwest, Inc. (NK) Company Bio
NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. The company was founded in 2002 and is based in Cardiff-by-the-Sea, California.
NK Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | 2,541.46% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | 0.00% |
2020 | 251.72% |
2019 | 226.72% |
Continue Researching NK
Want to do more research on NantKwest Inc's stock and its price? Try the links below:NantKwest Inc (NK) Stock Price | Nasdaq
NantKwest Inc (NK) Stock Quote, History and News - Yahoo Finance
NantKwest Inc (NK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...